List of Biostorage/Biorepositories Companies in United States - 78

Every day in the US, approximately 34 patients are removed from the transplant waiting list either because they die or they become too sick to receive a transplant. Our mission is to bring that number down to zero by developing innovative technology and services that will extend the safe preservation times for unused kidneys.

Alli Connect is a mental health care service for first responders that proactively promotes wellness and positive change in public safety.

Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more. Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis. Altogen Labs recently developed an `active bioremediation`​ process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.

American CryoStem Corporation (CRYO) is a clinical-stage biotechnology company, developing and delivering autologous (own self) regenerative therapies to treat diseases and conditions with significant unmet medical needs. We are prioritizing research targets and biological drug candidates where the disease biology is understood, and where our suite of technologies has the potential to make a difference. We are currently focused on mitigating the deleterious effects of post-concussion syndrome: https://clinicaltrials.gov/ct2/show/NCT04744051 and Long COVID/ PASC: Post Acute Sequelae of SARS-CoV-2 https://clinicaltrials.gov/ct2/show/NCT05669261 Translating Technology into Therapeutic Treatments™ Our core proprietary "end-to-end" patented technology platform consists of the “Collection-Processing-Cryobanking and Delivery to Point-of-Care” of Adipose Tissue (AT) and Adipose-Derived Mesenchymal Stem Cells (MSCs). Our Platform is configured to produce large quantities of autologous mesenchymal stem cells for treatments as needed, "on-demand". Through a single tissue collection, an autologous master cell sample is manufactured and cryopreserved for a lifetime of personalized treatments. Naturally, pure and simple.™

Animal Biotech Industries, Inc. is a private corporation that was established in 1990 to support the biomedical research community by supplying them with high quality post mortem tissues, organs and glands. To this end, ABI was conceived and is currently operated by scientific professionals who have dedicated themselves to producing superior animals and tissues as well as superior service.

About Anju Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company's flagship products, reduce complexities in the drug and device discovery and commercialization process allowing our customers to enhance the quality of their patients' lives. Customer First Our mission is to always be a customer-first organization, powered by a passionate team, providing best-value life science solutions paired with an excellent customer experience to simplify the complexities of life science information management. Driving Impactful Results Anju solutions are used by large, mid-sized, and small pharmaceutical companies, clinical research organizations (CROs), and medical device companies as well as full-service medical marketing, market research, and communications agencies. Our technologies facilitate data flow between our solutions and seamless communication with third-party systems, providing a unique opportunity for our customers to leverage critical information and drive impactful results. Experienced Leadership Anju is a portfolio company of Abry Partners, which is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5 billion of capital across their active funds.

At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government. With a history of scientific contributions spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological reference materials and data, and is a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, partnerships, and people provide the global scientific community with credible, advanced, model systems to support complex research and innovations in basic science, drug discovery, translational medicine, and public health. ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland. Visit atcc.org to learn more.

Atlas Data Storage is a technology company building end-to-end DNA data storage.

Azenta (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

Bay BioSciences provides high quality human biomaterials, fresh frozen human tissues, FFPE Tissue Blocks, bio fluids like whole blood from diseased and normal subjects, serum, plasma and other blood products. Bay BioSciences specializes in characterized and documented human bio-specimens for research and development projects and is a leading global biobank offering vital products and services facilitating breakthroughs in translational medicine, genetics, drug discovery, biomarker research, companion and molecular diagnostics.

TheBEI ResourcesRepository is a central repository, established by the National Institute of Allergy and Infectious Disease, that supplies organisms and reagents, such asSARS-CoV-2, to the broad community of microbiology and infectious diseases researchers.

We are a one-of-a-kind resource built for the future of life science research​. BocaBio is a hybrid CRO serving the pharmaceutical, biotech, and IVD industries​ ISO-certified Biobanx biospecimen inventory ​ ACRP and CCRA-certified clinical research services​ CLIA-certified and CAP-accredited reference laboratory services We help pharmaceutical and IVD research companies develop tomorrow's therapies Our biobank, CRO, and reference lab services enable: Pharmaceutical companies to develop novel therapeutic drugs. IVD companies to develop innovative diagnostic technologies Biotech companies to conduct critical research.

Catalog is developingtechnology to store digital information in DNA molecules.

CellPort Software's secure, compliant, SaaS-based application suite defines and manages all assay workflows, activities, equipment, materials, personnel, data/calculations and projects used by CROs, CMOs, research institutions, bio-pharma companies and regulatory authorities in assay development and biomanufacturing at all stages of development (R&D, GLP, GMP). The CellPort Cell Culture Suite combines the end-to-end laboratory inventory and process management of a Laboratory Information Management System (LIMS) with the highly repeatable QC and manufacturing focus of an Laboratory Execution System (LES).

Celltex Therapeutics Corporation is a Houston, Texas-based biotechnology company focused on spearheading breakthroughs in regenerative medicine using adult, autologous Mesenchymal Stem Cells (MSCs).

Centrillion Tech’ mission is to empower researchers, physicians and consumers to have responsible and cost effective access to genomic information and to advance personalized health care, molecular diagnostics and individualized wellness management. Founded in 2009, Centrillion Biosciences'​ research and product development operation is focused on novel bridging technologies that solve critical problems in large-scale genomic analyses (including sequencing) and informatics. Our service operation has provided high-quality genomic services and has been well received by academic and industrial customers

Lifechanging breakthroughs like cell and gene therapy are driving a medical revolution. But a lack of purpose-built development and manufacturing tools keeps these treatments from reaching more patients. At Charter Medical, we're on a mission to evolve single-use cell processing step-by-step with the needs of the biopharmaceutical innovators who count on us. With proven customization capabilities and an innovation roadmap that includes pioneering design and biomaterials. With industry-leading expertise and continuous improvement to simplify and standardize biomanufacturing systems so they can scale reliably. And with a deep commitment to responsiveness, collaboration and urgency. Because we know single-use advances are essential to helping our clients make revolutionary therapies more accessible to patients who need them – now.

Their mission is to accelerate insights and outcomes for patients through leading real-world data, AI technologies, and scientific expertise in partnership with the leading biomedical innovators, healthcare providers, and medical societies.

Cureline is a global precision and translational medicine CRO located in California (USA). With more than a hundred validated clinical partners in 20 countries, HBS repository in San Francisco Bay area and excellence in laboratory services, Cureline provides a full spectrum of translational research services: global regulatory affairs, custom protocol HBS biobanking, histopathology & digital pathology, molecular and cellular lab services, small animal studies and cell and gene therapy (ATMP) solutions. Since 2003 Cureline is a global leader in commercial biobanking and biomedical research services with a focus on targeted drug R&D, biomarker research and companion diagnostics development.

Cytologics specializes in customized procurement of human-derived biological products and services for biomedical research, drug discovery and cellular therapy process development. The Company’s supplier network of FDA-registered, GMP-compliant blood collection centers ensures fresh donor material is available to customers from the Cytologics isolation laboratory. Human biological material, including peripheral blood, is isolated into various primary cell types and proteins for fresh and frozen distribution to life science customers. We make it easy to find the right cells to advance your research. All products are well-characterized, tested for blood borne pathogens and guaranteed for cell viability and purity. We also offer a wide range of research services to support your basic and translational research activities.

Diagnostic testing for patients across all rare genetic diseases, including Cystic fibrosis, Fabry disease, Epilepsy, Hemophilia, all types of hereditary cancers, and cell and gene therapy.

DNAli is a biotechnology company that specializes in unlocking the full world of DNA through low-cost production of best-in-class DNA.

Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

Frontier Scientific Solutions (FSS) is a contract service organization (CSO) which supports the life science industry by offering cGMP temperature-controlled storage, distribution, and logistic services. Drug development and commercialization require continuous temperature monitoring and control. Frontier's diverse offerings protect product integrity throughout the pharmaceutical supply chain. FSSs' validated software, cGMP storage and drug distribution facility, industry expertise and stringent quality standards support this objective throughout packaging, storage and distribution.

We are building the largest longitudinal cohort in the Americas to power precision health at scale for all. Our goal is to improve diagnostic testing and accelerate drug discovery in diverse underserved populations. We are focused on Latin America and our diaspora populations throughout the world including founder populations in the Americas, those who identify as Hispanic/Latino, Black or African American, Asian American, American Indian/Alaska Native, First Nations, and Native Hawaiian/Pacific Islander as well as people who self identify as belonging to two or more of these groups. Core to our mission is building trust with the communities we serve and long term partnerships with communities, researchers, clinicians, and most of all patients and their families. This is your biobank and for the benefit of all. If we build it, we can decide how the data are used. And no one is going to do it for us, so let’s roll up our sleeves and “time to build.” Join us! Este biobanco es tuyo y para todo el continente porque si lo construimos juntos podemos decidir cómo se usan los datos y con que fines. Nadie lo va a hacer por nosotros así que bienvenido a nuestro esfuerzo. Unete!

Gnosko provides the only real-time automation solution in the Life Sciences Industry. Through close collaboration with our clients, we pinpointed a crucial challenge: even though they worked in state-of-the-art labs with advanced automated tools, many struggled with outdated inventory management practices. Motivated by a dedication to help others, we embraced an opportunity. Our vision extended beyond mere distribution – we evolved into partners with our clients, often being called “an extension of their team”. By grasping our customers’ business, applications, processes, and obstacles, we provide comprehensive solutions that empower advancement at an accelerated pace. We blend technology and a customer-focused strategy with our top-tier supplier network to simplify laboratory inventory management.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Imagene AI is democratizing precision medicine with multi-modal foundation models and an end-to-end OI Suite. Our living intelligence engine integrates imaging, molecular, and clinical data to make every trial more responsive, every insight more actionable, and every patient journey more personalized.

At Iridia, we stand at the intersection of blockchain, molecular science, robotics, and artificial intelligence. We’re pioneering advancements that redefine the capabilities of information storage, commerce and trust at the molecular level. We offer our clients and partners unparalleled business opportunities, heralding a new era of industry transformation. We're about to emerge from stealth.

The mission of the Department of Energy is to ensure America's security and prosperity by addressing its energy, environmental, and nuclear challenges through transformative science and technology solutions. Goal 1: Science and Energy — Advance foundational science, innovate energy technologies, and inform data driven policies that enhance U.S. economic growth and job creation, energy security, and environmental quality. Goal 2: Nuclear Security — Strengthen national security by maintaining and modernizing the nuclear stockpile and nuclear security infrastructure, reducing global nuclear threats, providing for nuclear propulsion, improving physical and cybersecurity, and strengthening key science, technology, and engineering capabilities Goal 3: Management and Performance — Position the Department of Energy to meet the challenges of the 21st century and the nation's Manhattan Project and Cold War legacy responsibilities by employing effective management and refining operational and support capabilities to pursue departmental missions

KIOXIA America is a technology company that specializes in flash memory and solid state drives, offering innovative data storage solutions with a focus on high performance and reliability.

Kwokman Diagnostics was founded and developed to help the fast paced sports broadcast industry return to work through accurate and quick results COVID19 testing. Through the initial journey and scope, we realized that a variety of companies would benefit from rapid turnaround results. Therefore we partnered with a number of labs, healthcare workers and logistics companies to ensure an end to end solution for any industry.

LabConnect improves lives by partnering with pharma/biotech companies and clinical research organizations (CROs) to accelerate the development of new medicines around the world. An independent, global, one-stop-shop focused on delivering central laboratory services that are tailor-made, timely, and flexible, LabConnect provides unparalleled program oversight and support to meet the evolving study demands from traditional to increasingly complex trials. With deep and unmatched experience, LabConnect's team of scientific experts serves as an extension of our client's clinical teams, quickly coordinating all laboratory-related needs and providing end-to-end analytical and logistical solutions. Offering a full suite of services from real-time sample tracking and data integration to groundbreaking scientific support services, LabConnect is the global partner of choice for central laboratory services. For more information, visit www.labconnect.com

Lieber Institute for Brain Development is a research institute focused on advancing understanding of brain development and disorders.

Microsoft is a technology company that offers a wide range of software, cloud computing services, hardware, and artificial intelligence solutions.

Mindera Health™ is commercializing scalable extraction technology and data analysis to report a patient’s individual transcriptomic data. Mindera’s technology creates Dermal Intelligence™, actionable information for payers, providers and patients. The company’s flagship test, Mind.Px, uses both a dermal biomarker patch and Machine Learning to determine a patient’s receptivity to very expensive psoriasis biologics. This information is valuable to payers, who can save thousands of dollars per biologic patient using Mind.Px at the outset of prescription. Mind.Px is the first test in a large planned product pipeline, including psoriatic arthritis and eczema biologic receptivity.

Mirador Therapeutics is a next-generation precision medicine company focused on immunology and inflammation. The company's Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to accelerate the next generation of precision medicines for immune-mediated diseases.

Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company's patented Fully Enzymatic Synthesis (or FES™), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of Molecular Assemblies, Inc.

Moleculera Biosciences offers advanced testing services in a fully-accredited CLIA/COLA clinical laboratory specializing in autoimmune neurobiology. As pioneers focusing on neuropsychiatric disorders caused by molecular mimicry, we offer the Autoimmune Brain Panel™, an aid to a physician's diagnosis of autoimmune-based neuropsychiatric disorders. The Autoimmune Brain Panel™ helps identify whether an individual's neurologic/psychiatric symptoms, such as obsessive compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and sometimes behaviors associated with Autism Spectrum Disorders, could be caused by a treatable autoimmune condition triggered by common infections.

Nashville Biosciences is leveragingresources and proprietary analytical methods to help improve the prevention, diagnosis and treatment of a wide range of diseases.

With over 20 years of expertise, NorthEast BioAnalytical Laboratories LLC, also known as NorthEast BioLab, specializes in providing top-notch GLP and clinical bioanalytical services. We are proud to be trusted partners to hundreds of industry sponsors and renowned investigators in the biotechnology sector. We are an independent, full-service facility that adheres to GLP/GCLP compliance. Our FDA-audited and DEA & CT State Schedule II-IV approved facility is managed by Watson LIMS, ensuring seamless operations. Our dedicated scientists and project teams excel in assay development, optimization, troubleshooting, and full method validation on various platforms, including Ligand Binding Assays (ELISA, Meso Scale Discovery, Luminex, Western Blotting, etc.), Mass Spectrometry Liquid Chromatography (LC-MS/MS, HPLC-UV/DAD/Fluorescence, etc.), and Cell And Gene Therapy platforms (Cell-Based Assay, qPCR and dPCR). With our custom assay development services, we offer comprehensive solutions for pharmacokinetics analysis studies, toxicokinetic safety testing, immunogenicity assay, multiplex cytokine analysis, PD biomarker assessment, biochemical assay, mechanism of action, gene expression, copy number variation investigations, etc. Since its establishment in 2003, our team of dedicated biologists and chemists has been committed to empowering mission-driven biotech. With our vast experience and technical expertise, we deliver exceptional preclinical study and clinical assay development services as a Contract Research Organization (CRO). At NorthEast BioLab, we prioritize top quality and industry-leading turnaround time while offering highly competitive pricing. Our team is dedicated to helping you meet the stringent timelines of various milestones throughout your drug development life-cycle. SPEAK TO OUR SCIENTISTS today to expedite your bioanalytical assay development, validation, and sample analysis!

Obatala Sciences offers contract research services and research products to laboratories in industry and in academia. Our clients include major pharmaceutical companies, US government entities, contract research organizations, non-profit organizations, and academic research laboratories. Our areas of expertise include obesity, diabetes, energy metabolism, musculoskeletal system biology, and wound healing. ObaCell™, a unique fat tissue model, is a great tool for disease modeling and drug screening. Obatala Sciences can provide data in various areas depending on your interest including proteomics, genomics, functionality, and adipokine secretion. We also have the capability of forming white or brown fat tissue upon request.

OriGen Biomedical is a leading producer of cryopreservation and cell culture products. OriGen’s focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. OriGen Biomedical® products are designed with the patient and user in mind and we strive to maintain excellent customer service to ensure that patient care is the priority. OriGen is a growing, privately-held medical device manufacturer founded in 1997 and headquartered in Austin, Texas. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention of improving patient health. OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. Our European distribution center serves to reduce the time to patients by providing stock products for quicker turnaround times out of the Netherlands.

PERPETUATE, INCpreserves DNA from exceptional pets, horses and other animals. These cryopreserved cells have been and are being used to clone the special animals, preserve their bloodlines and for medical purposes.

Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients.

We bring certainty to the unknown. Through Uvance Wayfinders, we leverage cutting-edge technology to empower our customers to build confidence and set their paths forward. This collaborative journey enables a knowledge ecosystem that delivers better outcomes for businesses, society and the planet, creating a brighter and more sustainable future. Join us on this journey of Wayfinding for new potential.

Pluristyx is a pioneering company at the forefront of stem cell technologies. With a mission to revolutionize the field of regenerative medicine, Pluristyx develops innovative solutions that empower breakthroughs in stem cell therapies. The company's proprietary platform, panCELLa, represents a transformative leap in stem cell research, offering enhanced freedom to operate and unparalleled potential for medical advancements at a significantly accelerated timeline. Operating from two cutting-edge North American sites, Pluristyx is dedicated to driving progress and innovation in the realm of stem cell therapies. In July of 2023 Pluristyx and panCELLa merged. Pluristyx offers a portfolio of iPSC-based products and services to provide end-to-end client support in early product development, while panCELLa offers an array of unique and effective technologies with particular strength in gene editing. As one company, Pluristyx and panCELLa offer an enlarged portfolio whose long-term focus is to become the global leader in clinical-grade, genetically modified, “off-the-shelf” iPSCs with the lowest barrier to entry for cell therapy development, providing clients with the fastest speed to clinic and the best route to commercialization.

Precision for Medicine is an industry-leading global clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients’ insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with embedded experience in oncology and rare disease. With over 2000 dedicated professionals and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe.

PrecisionLife is the clinical-stage precision medicine company for complex chronic diseases. Creating better diagnostic tools and more personalized treatment options for patients with unmet medical needs. Our analytics and AI is unique in its understanding of causal disease biology. Identifying biomarkers to stratify patients by molecular mechanism of either their disease or drug response and link individuals to the drug targets, trials and treatments that will benefit them. With these insights we significantly increase the probability of success throughout the biopharma and healthcare value chain. Accelerating, informing and de-risking drug discovery and clinical development, building highly predictive diagnostics, and in launching more personalized and preventative medicines. To learn more, visit precisionlife.com.

PrecisionMed is a provider of products and services supporting advancements in genetics, drug discovery, biomarker research, and molecular diagnostics with a focus on high-quality human biological material.

Precision provides full sample management services in our Biological Freezers and Pharmaceutical stability chambers with four facilities across the United States. Our cGMP facilities (Wilson, NC; Hopedale, MA; Fort Lauderdale, FL; and El Segundo, CA) include the following features: • All Freezers, rooms, and Ambient Storage are fully validated. • 24/7/365 monitored Fire Alarm and Security system. • Access restricted with keyed access to main building, storage area, and individual chambers. Access doors are alarmed and camera monitored. • 21 CFR, Part 11 compliant monitoring system recording conditions with calibrated probes on all rooms/freezers. System does remote notification to alert personnel of alarms during non-business hours. • Backup generator to power the entire facility if there is a power outage, plus back-up conditioners/freezers are on hand if needed. Conditions available: Long-Term and Intermediate conditions of 25°C/40%Rh, 25°C/60%Rh, 30°C/65%Rh, 30°C/75%Rh, 30°C/35%Rh Accelerated storage of 40°C/not more than (NMT) 25%Rh, 40°C/75%Rh Refrigerated and Freezer storage conditions of 2°C - 8°C (5°C), -20°C, -80°C, LN2 Ambient storage conditions of 15°C - 30°C

Our mission at Predictive Oncology is to change the landscape of oncology drug discovery and enable the development of more effective therapies in the treatment of cancer. By harnessing the power of machine learning, scientific rigor and biologics, we can improve the probability of success and advance drug compounds with a higher degree of confidence. We invite you to follow us to stay up-to-date about our latest developments.

Our mission at Predictive Oncology is to change the landscape of oncology drug discovery and enable the development of more effective therapies in the treatment of cancer. By harnessing the power of machine learning, scientific rigor and biologics, we can improve the probability of success and advance drug compounds with a higher degree of confidence. We invite you to follow us to stay up-to-date about our latest developments.

Service company providingdrug discovery assay platforms that build upon our extensive experience in single cell analysis and multiplexing.

Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients' insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with embedded experience in oncology and rare disease. With over 2000 dedicated professionals and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe.

Protabit LLC engineers proteins for industrial, agricultural, and healthcare applications. The company's platform technology is being developed via a strategic partnership with the Monsanto Company and the California Institute of Technology. Protabit's protein engineering approach combines computational modeling with high-throughput screening and directed evolution to expand the diversity of protein sequences that can be explored to produce novel proteins.

Based on RUCDR Infinite Biologics, which was founded in 1999 to provide biobanking services and biomaterials to advance the genetic disease research of partners in the public and private sectors. Following the spinout, Infinity Biologix said it will provide sample collection, processing, storage, and analytical services integrated with scientific and technical support in both the research and clinical arenas.COVID-19: COVID-19 Saliva test. In April 2020, IBX (formerly Rutgers RUCDR Infinite Biologics) received the first FDA Emergency Use Authorization (EUA) enabling the use of saliva tests to detect the presence of the SARS-CoV-2 coronavirus. Since then, a revised EUA for anat-home saliva sample collectionwas also approved.

At Seagate, we're storing, protecting, and activating the world's data as explosive growth in cloud, AI, and machine learning drive the demand for breakthrough technology and mass-capacity storage solutions. It starts with innovation—where we put some of the most sophisticated nanoscale engineering and material science on the planet to work while bringing circularity and sustainability to our products. The result is industry-leading areal density that powers a full portfolio of devices, systems, and services for every data-driven ecosystem imaginable—from edge to cloud. Inspired by our values, we push beyond what's possible to create breakthrough technology so that you can safely store your data, and easily unlock its value. Learn more at Seagate.com.

Simplify Genomics is a San Diego-based biotechnology company that provides clinical whole genome reporting and genome exploration at the speed of thought using its proprietary genome search engine.

SmartHealth Dx develops precision diagnostics that address unmet clinical needs in pathology and vascular inflammation for advancing today's standard.

Founded in 2007, Spaulding Clinical is a full-service, state-of-the-art paperless Phase I clinical pharmacology unit. Our facility, originally a hospital, features fully integrated bedside electronic data capture and sets the standard for patient care. We specialize in IND-enabling clinical pharmacology studies, cardiovascular safety, and clinical proof of concept. We provide expertise on study design, offering in-house medical writing, clinical data management, biostatistics, project management, clinical laboratory, and PK/PD analysis. For high-quality data to inform your decisions, Think Spaulding First. To learn more, visit spauldingclinical.com.

Cancer patients get one chance to save their tumor tissue. Don't throw it away. Unfortunately most tissue is routinely discarded, but SpeciCare aims to change that. Your tumor tissue is as unique as a fingerprint, and holds the key to more effective, precision treatments, leading to improved outcomes, and a better quality of life. We work with cancer patients, and their care team, to uncover treatment options not available without SpeciCare's innovative protocol. Call today to speak to one of our patient advocates. We care about you.

Stanford University is a Higher Education institution that focuses on research, innovation, and providing educational services.

Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies.

𝗧𝗛𝗘 𝗡𝗘𝗫𝗧 𝗚𝗘𝗡𝗘𝗥𝗔𝗧𝗜𝗢𝗡 𝗢𝗙 𝗘𝗚𝗚 𝗔𝗡𝗗 𝗘𝗠𝗕𝗥𝗬𝗢 𝗦𝗧𝗢𝗥𝗔𝗚𝗘 TMRW Life Sciences is a fertility technology company that provides safety and transparency to modernize and transform egg and embryo storage.   The current system is manual, outdated, and stressful for embryologists and clinicians. Automatization and state-of-the-art technology identify, track and remotely monitor frozen eggs and embryos. TMRW is a scalable solution for overcrowded clinics that have unintentionally become storage facilities since the rise in people seeking fertility treatments. Named Fast Company's #1 Most Innovative Biotech Company in 2022, TMRW is in leading clinics across the US and will soon be available in the UK and Europe.

TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on developing a pipeline of T cell receptor-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation; and TSC-200, TSC-201, TSC-202, and TSC-203 for the treatment of solid tumors. The company has a collaboration and license agreement with Novartis Institutes for Biomedical Research, Inc. to discover and develop novel TCR-T therapies. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. Twitter @TwistBioscience Facebook facebook.com/TwistBioscience YouTube youtube.com/TwistBioscience #WeMakeDNA

US Biolab is a global commercial biobank and human biospecimen CRO providing solutions to biopharmaceutical and academic researchers. We are specializing in contract services for human sample validation studies such as sample collections & histology services. Our expertise is precision medicine and biomedical research projects including biomarker R&D and translational medicine. Our Biobank/repository preserving more than 300,000 high-quality bio-samples, we has developed more than 300 types of tissue microarray and cell microarray products. Sample selection from our bank and customization are both available to build the most satisfactory tissue microarrays. Partnering with us allows you to greatly accelerate and improve your research with guaranteed quality.

Valted Seq is a discovery stage biopharmaceutical company spearheaded by world-renowned scientists Dr. Ted Dawson and Dr. Valina Dawson of Johns Hopkins University. The company was founded on the belief that a deeper understanding of neurodegenerative pathways is essential to develop precision therapeutics and identify novel biomarkers for some of the most challenging neurodegenerative diseases, including Alzheimer’s and Parkinson’s. Valted Seq is part of the D&D Pharmatech/Neuraly family of companies, which works hand in hand with leading medical research institutions to advance groundbreaking healthcare innovations. ValtedSeq is focused on the advancement of NextGen sequencing at the single cell level, as well as developing assays for diagnostic biomarkers,

Our Mission: To provide the highest-quality stem cell preservation service and care to our patients, families, and their physicians. We at ViaCord believe these words are much more than just a promise. They are the commitment we live by. Our Origins: ViaCord was established in 1993 to give expectant parents an opportunity to bank their children's cord blood with comfort and security. Prior to launching our Cord Blood Banking Service, ViaCord conducted extensive research and validation studies to set high standards regarding the collection, processing, and storage of cord blood. ViaCord worked closely with the following institutions during our development: * Obstetrics Program at Brigham and Women's Hospital in Boston, MA * The Christ Hospital in Cincinnati, OH * The University of Cincinnati's Hoxworth Blood Center, OH ViaCord's headquarters are located in Cambridge, Massachusetts; a recognized global hub of biotechnology. All cord blood collections are processed and stored at our cord blood storage facility outside of Cincinnati.

Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection of cancer. The BeVigilant™ OraFusion System aids clinicians with identifying patients at risk for oral cancers. It is simple, accurate and cost-effective, empowering healthcare practitioners to improve lives through earlier intervention. The BeVigilant™ OraFusion System, the first and only technology that measures tumor-initiating and stem cell associated biomarkers – markers clinically validated to be associated with oral cancer – was developed to aid clinicians in the early detection of oral cancer. The point-of-care BeVigilant™ OraFusion System uses a simple collection method that is easy to administer and non-invasive for the patient. The test has the potential to benefit adults at risk of oral cancer, with particular emphasis on high-risk populations (i.e., current and former tobacco users, those who consume excessive alcohol, and people with human papillomavirus, HPV-16). The BeVigilant™ OraFusion System is CE Marked and available in select markets outside of the United States. The BeVigilant™ OraFusion System is not available for sale in the U.S. Leadership: Bill Brodie, Chief Executive Officer Robert T. Hamilton, CPA, Chief Financial Officer Dragan Nebrigic, Ph.D., Chief Operating Officer Ben Beckham, Chief Commercial Officer Michael Donovan, M.D. Ph.D., Chief Clinical Officer

The company operates a GMP biorepository and performs bioservices such as cell banking, tissue banking, and clinical sample management.